Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00121095

Extrait

The purpose of this study is to investigate the safety, tolerability and anti-tumor effects of treatment with samarium Sm-153 lexidronam in combination with docetaxel in patients with castrate metastatic prostate cancer.


Critère d'inclusion

  • Prostatic Neoplasms

Liens